RAF1 and cancer: The aberrant mitogenic signaling in Ras-driven cancer cells largely depends on the increased recruitment of the downstream effectors Raf1, from the constitutively active Ras oncoproteins (Metcalfe et al., 1993; Warne et al., 1993).